Browse

Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung

DC Field Value Language
dc.contributor.authorKim, Young Tae-
dc.contributor.authorPark, Sun Jung-
dc.contributor.authorLee, Seung Hee-
dc.contributor.authorKang, Hee Jung-
dc.contributor.authorHahn, Seokyung-
dc.contributor.authorKang, Chang Hyun-
dc.contributor.authorSung, Sook Whan-
dc.contributor.authorKim, Joo Hyun-
dc.date.accessioned2009-11-19T03:48:46Z-
dc.date.available2009-11-19T03:48:46Z-
dc.date.issued2005-11-01-
dc.identifier.citationJ Thorac Cardiovasc Surg. 2005 Nov;130(5):1378. Epub 2005 Oct 13.en
dc.identifier.issn1097-685X (Electronic)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16256792-
dc.identifier.urihttps://hdl.handle.net/10371/13613-
dc.description.abstractOBJECTIVES: DNA hypermethylation in promoter regions has been studied for various types of cancer. However, there is no clear evidence that shows whether methylation status can predict long-term survival in patients with lung cancer. METHODS: We collected tissues from 72 patients with lung adenocarcinomas. The cancer and normal lung tissues were tested for DNA hypermethylation by using methylation-specific polymerase chain reaction. The genes investigated were p16INK4alpha(p16), retinoic acid receptor beta-promoter (RARbetaP2), death-associated protein kinase (DAPK), O6-methylguanine-DNA-methyltransferase (MGMT), and glutathione-S-transferase P1 (GSTP1). The status of the DNA methylation was analyzed, and we focused on long-term outcomes, as well as other clinical variables. RESULTS: DNA hypermethylation was observed in 83% for p16, 63% for RARbetaP2, 32% for DAPK, 17% for MGMT, and 46% for GSTP1 from the cancer tissue. From normal lung tissue, the results of methylation were positive in 75% for p16, 24% for RARbetaP2, 10% for DAPK, 6% for MGMT, and 33% for GSTP1. During the mean follow-up period of 18 +/- 11 months (1-40 months), 25 (35%) patients experienced recurrence, and 13 died. In multivariable analysis, old age (>60 years, P = .007), male sex (P = .004), unmethylation of DAPK from cancer tissue (P = .045), and hypermethylation of RARbetaP2 from normal tissue (P = .000) were risk factors for poor survival. Pathologic stage (P = .023), unmethylation of DAPK from normal tissue (P = .043), and hypermethylation of RARbetaP2 from normal tissue (P = .030) were risk factors for disease-free survival. CONCLUSIONS: DNA methylation status of CpG islands seems to be a useful predictor of long-term outcome for adenocarcinoma of the lung. However, because the predictive power is still low, further studies, including those with multiple genes, are necessary to increase its usefulness in the clinical setting.en
dc.language.isoen-
dc.publisherElsevieren
dc.subjectAdenocarcinoma/genetics/*metabolism/mortality/pathologyen
dc.subject*CpG Islands/geneticsen
dc.subject*DNA Methylationen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectLung Neoplasms/genetics/*metabolism/mortality/pathologyen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectNeoplasm Stagingen
dc.subjectPrognosisen
dc.subjectPromoter Regions, Geneticen
dc.subjectSurvival Rateen
dc.titlePrognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lungen
dc.typeArticleen
dc.contributor.AlternativeAuthor김영태-
dc.contributor.AlternativeAuthor박선정-
dc.contributor.AlternativeAuthor이승희-
dc.contributor.AlternativeAuthor강희정-
dc.contributor.AlternativeAuthor한서경-
dc.contributor.AlternativeAuthor강창현-
dc.contributor.AlternativeAuthor성숙환-
dc.contributor.AlternativeAuthor김주현-
dc.identifier.doi10.1016/j.jtcvs.2005.06.015-
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Thoracic Surgery (흉부외과학전공)Journal Papers (저널논문_흉부외과학전공)
Files in This Item:
There are no files associated with this item.
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse